MDB is trading at 3.7% down now at $316.96 after a sharp decline that extends a multi-day losing streak, with no major company-specific news, earnings, or analyst downgrades reported as of November 21, 2025. The most recent analyst action was Truist Securities reiterating a Buy rating and a $400 price target this morning, which is not a negative catalyst[4]. The broader market is trading higher today, with the S&P 500 up 0.35% and the Nasdaq up 0.49%, so MDB's decline is not in line with overall market sentiment. The drop follows a series of recent declines, including a 2.4% fall yesterday, but no clear reason for today's outsized move has been cited in news or analyst commentary.